EUVIMEDEUVIMED entdecken
FallberichtOpen Access

A Case Report of Systemic Allergic Reaction to the Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonist Tirzepatide

Trang Thi Bich Le, Le Huu Nhat Minh, Pooja Devi, Nabila Islam, Issac Sachmechi

Cureus · 01.01.2024

DOI: 10.7759/cureus.51460 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cureus, erschienen am 01.01.2024. Verfasst von Trang Thi Bich Le und 4 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, Department of Cardiovascular Research, Methodist Hospital, Merrillville, USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This report examines a case of systemic hypersensitivity to tirzepatide in a patient with type 2 diabetes. Tirzepatide (Mounjaro®), a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor, has recently gained FDA approval. Additionally, a literature review was conducted to summarize recent research on tirzepatide's effectiveness and safety. A 67-year-old woman, previously treated with basal insulin, metformin, and semaglutide (a GLP-1 agonist), experienced severe disseminated pruritus and a generalized urticarial rash after her first dose of tirzepatide. This reaction, which subsided with antihistamines, raises questions about possible immunoglobulin E-mediated hypersensitivity. The report highlights the need for increased vigilance regarding allergic reactions to new diabetes medications, particularly in the context of GIP/GLP-1 receptor agonists.

Schlagwörter

Stichwörter der Autor:innen

allergic reactiongip/glp-1 receptor agonisthypersensitivitysafetytirzepatide

Autor:innen und Institutionen

  • Internal Medicine, Department of Cardiovascular Research, Methodist Hospital, Merrillville, USA.
  • College of Medicine, Taipei Medical University, Taipei, TWN.
  • Research Center for Artificial Intelligence in Medicine, College of Medicine, Taipei Medical University, Taipei, TWN.
  • Internal Medicine, Maimonides Medical Center, New York, USA.
  • Internal Medicine, Mymensingh Medical College, Dhaka, BGD.
  • Internal Medicine, Queens Hospital Center, New York, USA.

Zitieren

APA

Le, T. T. B., Minh, L. H. N., Devi, P., Islam, N., & Sachmechi, I. (2024). A Case Report of Systemic Allergic Reaction to the Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonist Tirzepatide. Cureus. https://doi.org/10.7759/cureus.51460

Vancouver

Le TTB, Minh LHN, Devi P, Islam N, Sachmechi I. A Case Report of Systemic Allergic Reaction to the Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonist Tirzepatide. Cureus. 2024. doi:10.7759/cureus.51460

BibTeX
@article{Le2024,
  author = {Le, Trang Thi Bich and Minh, Le Huu Nhat and Devi, Pooja and Islam, Nabila and Sachmechi, Issac},
  title = {A Case Report of Systemic Allergic Reaction to the Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonist Tirzepatide},
  journal = {Cureus},
  year = {2024},
  doi = {10.7759/cureus.51460}
}
Kostenlos starten →